NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Autoimmune diseases occur when the body's immune system malfunctions and mistakenly attacks healthy cells, tissues, and organs. Strong data on the incidence and prevalence of autoimmune diseases are limited, but a 2009 study estimated the prevalence of autoimmune diseases in the U.S. to be 7.6 to 9.4 percent, or 25 to 31 million people today. This estimate, however, includes only 29 autoimmune diseases, and it does not account for increases in prevalence in the last decade. By some counts, there are around 150 autoimmune diseases, which are lifelong chronic illnesses with no known cures. The National Academies of Sciences, Engineering, and Medicine was asked to assess the autoimmune disease research portfolio of the National Institutes of Health (NIH). Enhancing NIH Research on Autoimmune Disease finds that while NIH has made impressive contributions to research on autoimmune diseases, there is an absence of a strategic NIH-wide autoimmune disease research plan and a need for greater coordination across the institutes and centers to optimize opportunities for collaboration. To meet these challenges, this report calls for the creation of an Office of Autoimmune Disease/Autoimmunity Research in the Office of the Director of NIH. The Office could facilitate NIH-wide collaboration, and engage in prioritizing, budgeting, and evaluating research. Enhancing NIH Research on Autoimmune Disease also calls for the establishment of long term systems to collect epidemiologic and surveillance data and long term studies (20+ years) to study disease across the life course. Finally, the report provides an agenda that highlights research needs that crosscut many autoimmune diseases, such as understanding the effect of environmental factors in initiating disease.
Contents
- The National Academies of SCIENCES • ENGINEERING • MEDICINE
- COMMITTEE FOR THE ASSESSMENT OF NIH RESEARCH ON AUTOIMMUNE DISEASES
- Reviewers
- Preface
- Acknowledgments
- Acronyms and Abbreviations
- Summary
- 1. Introduction
- 2. Background on Autoimmune Diseases
- 3. Overview of Select Autoimmune Diseases
- 4. Crosscutting Issues in Autoimmune Diseases
- 5. NIH Autoimmune Disease Research Efforts
- 6. Analysis of Institute and Center Autoimmune Disease Research Activity
- 7. Opportunities and Options for Enhancing Autoimmune Disease Research at NIH
- Appendix A. Committee Member and Staff Biographies
- Appendix B. List of Autoimmune Diseases
- Appendix C. Open Session Agendas
- Appendix D. Epidemiology: Select Diseases
- Appendix E. Mission Statements of NIH’s Institutes and Centers
- Appendix F. NIH Office of Autoimmune Disease Research Act of 1999
- Appendix G. Analysis of the NIH Autoimmune Disease Research Grant Portfolio: Methodology
- Appendix H. Topic Analysis of NIH Autoimmune Disease Research Grant Abstracts
Suggested citation:
National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH research on autoimmune disease. Washington, DC: The National Academies Press. https://doi.org/10.17226/26554.
Digital Object Identifier: https://doi.org/10.17226/26554
Library of Congress Catalog Number: 2022939055
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Printed in the United States of America
Created: May 10, 2022; Last Update: June 2, 2022.
- NLM CatalogRelated NLM Catalog Entries
- Monitoring the implementation of the national institutes of Health Strategic Plan for Women's Health and Sex/gender Differences research: Strategies and Successes.[Glob Adv Health Med. 2013]Monitoring the implementation of the national institutes of Health Strategic Plan for Women's Health and Sex/gender Differences research: Strategies and Successes.Tingen C, Nagel JD, Clayton JA. Glob Adv Health Med. 2013 Sep; 2(5):44-9.
- Review The Minderoo-Monaco Commission on Plastics and Human Health.[Ann Glob Health. 2023]Review The Minderoo-Monaco Commission on Plastics and Human Health.Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, et al. Ann Glob Health. 2023; 89(1):23. Epub 2023 Mar 21.
- Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.[Elife. 2020]Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.Vazquez SE, Ferré EM, Scheel DW, Sunshine S, Miao B, Mandel-Brehm C, Quandt Z, Chan AY, Cheng M, German M, et al. Elife. 2020 May 15; 9. Epub 2020 May 15.
- A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.[J Assoc Physicians India. 2023]A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.Bhakat B, Pal J, Das S, Charaborty SK, SircarMedical NR, Kolkata, RGKar, NorthBengal, Siliguri. J Assoc Physicians India. 2023 Jan; 71(1):1.
- Review Evidence Brief: Effectiveness of Intensive Primary Care Programs[ 2013]Review Evidence Brief: Effectiveness of Intensive Primary Care ProgramsPeterson K, Helfand M, Humphrey L, Christensen V, Carson S. 2013 Feb
- Enhancing NIH Research on Autoimmune DiseaseEnhancing NIH Research on Autoimmune Disease
Your browsing activity is empty.
Activity recording is turned off.
See more...